Rovira A, Alonso J, Córdoba J
Magnetic Resonance Unit, Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AJNR Am J Neuroradiol. 2008 Oct;29(9):1612-21. doi: 10.3174/ajnr.A1139. Epub 2008 Jun 26.
The term hepatic encephalopathy (HE) includes a spectrum of neuropsychiatric abnormalities occurring in patients with liver dysfunction. Most cases are associated with cirrhosis and portal hypertension or portal-systemic shunts, but the condition can also be seen in patients with acute liver failure and, rarely, with portal-systemic bypass and no associated intrinsic hepatocellular disease. Although HE is a clinical condition, several neuroimaging techniques, particularly MR imaging, may eventually be useful for the diagnosis because they can identify and measure the consequences of central nervous system (CNS) increase in substances that under normal circumstances, are efficiently metabolized by the liver. Classic MR imaging abnormalities include high signal intensity in the globus pallidum on T1-weighted images, likely a reflection of increased tissue concentrations of manganese, and an elevated glutamine/glutamate peak coupled with decreased myo-inositol and choline signals on proton MR spectroscopy, representing disturbances in cell-volume homeostasis secondary to brain hyperammonemia. Recent data have shown that white matter abnormalities, also related to increased CNS ammonia concentration, can also be detected with several MR imaging techniques such as magnetization transfer ratio measurements, fast fluid-attenuated inversion recovery sequences, and diffusion-weighted images. All these MR imaging abnormalities, which return to normal with restoration of liver function, probably reflect the presence of mild diffuse brain edema, which seems to play an essential role in the pathogenesis of HE. It is likely that MR imaging will be increasingly used to evaluate the mechanisms involved in the pathogenesis of HE and to assess the effects of therapeutic measures focused on correcting brain edema in these patients.
肝性脑病(HE)这一术语包括肝功能不全患者出现的一系列神经精神异常。大多数病例与肝硬化、门静脉高压或门体分流有关,但在急性肝衰竭患者中也可见到这种情况,极少数情况下与门体分流且无相关的内在肝细胞疾病有关。虽然HE是一种临床病症,但几种神经成像技术,尤其是磁共振成像(MR成像),最终可能对诊断有用,因为它们可以识别和测量中枢神经系统(CNS)中物质增加的后果,而这些物质在正常情况下是由肝脏有效代谢的。经典的MR成像异常包括T1加权图像上苍白球的高信号强度,这可能反映了锰组织浓度的增加,以及质子磁共振波谱上谷氨酰胺/谷氨酸峰升高,同时肌醇和胆碱信号降低,这代表了脑高氨血症继发的细胞体积稳态紊乱。最近的数据表明,与CNS氨浓度增加也相关的白质异常,也可以通过几种MR成像技术检测到,如磁化传递率测量、快速液体衰减反转恢复序列和扩散加权图像。所有这些MR成像异常在肝功能恢复后会恢复正常,可能反映了轻度弥漫性脑水肿的存在,这似乎在HE的发病机制中起重要作用。MR成像很可能会越来越多地用于评估HE发病机制中涉及的机制,并评估针对纠正这些患者脑水肿的治疗措施的效果。